Delivery Order SPE2DB22D1202-SPE2DB26FUEV5
Award Date 10/14/25
Potential Completion Date 10/15/25
Potential Value $8.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $210,550.92 on September 27, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) to support the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,248.66 on May 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of May 19, 2025, and performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,825.57 for BIKTARVY 50-200-25 mg tablets (30-count units) on August 20, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's Corporate Office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $55,560.43 for BIKTARVY 50-200-25 mg tablets (30-count units) by the Defense Logistics Agency on September 9, 2025. This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by September 10, 2025, with performance taking place at the company's Conshohocken facility. The award represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $48,473.90 and is scheduled for completion by August 13, 2025. The contract includes no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order valued at $31,805.90 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on June 3, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,727.91 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for $33.4K to supply Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for July 29, 2025, and work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $4,644.48 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $71,383.15 and an ultimate completion date of September 19, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....